Singh V, Srivastava D, Kotarya N, Ora M, Gambhir S. Pyomyositis as Presentation of Chemoport-related Infection in Breast Carcinoma:
18F-FDG PET/CT Findings.
Mol Imaging Radionucl Ther 2025;
34:76-78. [PMID:
39918102 PMCID:
PMC11827528 DOI:
10.4274/mirt.galenos.2024.46547]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Accepted: 07/21/2024] [Indexed: 02/16/2025] Open
Abstract
A Chemoport is frequently utilized in oncological patients for administering chemotherapy. However, inadequate care can lead to various infectious and non-infectious complications. Infection commonly presents as a local infection that can lead to life-threatening septicemia. Early diagnosis and intervention are necessary to reduce morbidity and mortality. We report a patient with breast cancer who underwent 18F-fluorodeoxyglucose positron (18F-FDG) positron emission tomography/computed tomography (PET/CT) due to suspicion of metastatic disease. 18F-FDG-PET/CT revealed pyomyositis involving multiple skeletal muscles and septic emboli in the lungs and identified the chemoport as a possible source of infection. The infection source was confirmed and the patient responded to anti-microbiological therapy.
Collapse